Top

Journal of Assisted Reproduction and Genetics

Published in:

01-02-2013

Ovarian stimulation protocols for onco-fertilty patients

Authors: Juliette Koch, William Ledger

Published in: Journal of Assisted Reproduction and Genetics | Issue 2/2013

Abstract

Purpose

To review options for ovarian stimulation before oocyte collection for fertility preservation for women with cancer or related diseases who require potentially sterilizing chemo- or radiotherapy.

Methods

Narrative review of current practice.

Results

Vitrification of oocytes and embryos has improved chances of pregnancy for this group of patients in recent years, increasing the uptake of fertility preservation before cancer treatment substantially. Strategies for ovarian stimulation for such patients should optimize oocyte yield whilst avoiding risk of ovarian hyperstimulation.

Conclusions

Best practice in ovarian stimulation can deliver good numbers of oocytes or embryos for cryopreservation with minimal risk of ovarian hyperstimulation for women under 36 years of age. Results are less encouraging for older patients.

Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251–66.

Song WY, Sun YP, Jin HX, Xin ZM, Su YC, Chian RC. Clinical outcome of emergency egg vitrification for women when sperm extraction from the testicular tissues of the male partner is not successful. Syst Biol Reprod Med. 2011;57:210–3. doi:10.3109/19396368.2011.566666.

Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239–46. doi:10.1093/humrep/deq146.

Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil Steril. 2010;93:467–74. doi:10.1016/j.fertnstert.2008.12.094.

Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009;27:450–5. doi:10.1055/s-0029-1241054.

Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentre study. Hum Reprod. 2012;27:1606–12.PubMedCrossRef

Vajta G, Nagy ZP, Cobo A, Conceicao J, Yovich J. Vitrification in assisted reproduction: myths, mistakes, disbeliefs and confusion. Reprod Biomed Online. 2009;19(Suppl3):1–7.PubMedCrossRef

Youssef MAFM, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011, Issue 1. Art. No.: CD008046. doi:10.1002/14651858.CD008046.

Stowitzki T. Ovarian stimulation in cancer patients. European Society of Human Reproduction and Embryology Campus Workshop: Cancer and Fertility. Heidelberg Nov14–15th 2008.

10.

Ozkaya E, San Roman G, Oktay K. Luteal phase GnRHa trigger in random start fertility preservation cycles. J Assist Reprod Gen. 2012;29:503–5.CrossRef

11.

Friedman BE, Pao S, Westphal LM, Lathi RB. Oocyte retrieveal following continued stimulation five days beyond ovulations yields live birth after frozen embryo transfer. J Assist Reprod Gen. 2012;29:433–5.CrossRef

12.

Kim SS, Donnez J, Barri P, et al. Recommendations for fertility preservation in patients with lymphoma, leukaemia and breast cancer. ISFP Practice Committee. J Assist Reprod Gen. 2012;29:465–8.CrossRef

13.

Checa Vizcaino MA, Chorchado AR, Cuadari ME, et al. The effects of letrazole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online. 2012;24:606–10.PubMedCrossRef

14.

Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrazole and gonadotropins in patients with breast cancer. J ClinOncol. 2008;26:2630–5.CrossRef

15.

Henes M, Henes JC, Neunhoeffer E, et al. Fertility preservation methods in young women with SLE prior to cytotoxic therapy: experiences from the FertiPROTEKT network. Lupus. 2012;21:953–8.PubMedCrossRef

16.

Peddie VL, Porter MA, Barbour R, et al. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJObsGyn. 2012;119:1049–57.

Title: Ovarian stimulation protocols for onco-fertilty patients
Authors: Juliette Koch
William Ledger
Publication date: 01-02-2013
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 2/2013
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-013-9947-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ovarian stimulation protocols for onco-fertilty patients

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2013

A study of meiotic segregation in a fertile human population following ovarian stimulation with recombinant FSH-LH

Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial

Progress in understanding human ovarian folliculogenesis and its implications in assisted reproduction

Scientific program for 6th world congress on mild approaches in assisted reproduction March 22–24, 2013 Nanjing, China

Impact of chromosomal heteromorphisms on reproductive failure and analysis of 38 heteromorphic pedigrees in Northeast China

Positive association of Apolipoprotein E4 polymorphism with recurrent pregnancy loss in Iranian patients